Skin Cancer

The AJMC® Skin Cancer compendium is a comprehensive resource for clinical news and expert insights about melanoma and other skin cancers.

Latest News

The FDA has issued a complete response letter for RP1 plus nivolumab for advanced melanoma after a PD-1 inhibitor–containing regimen. | Image credit: ra2studio - stock.adobe.com
RP1 Plus Nivolumab Receives CRL for Advanced Melanoma

July 24th 2025

The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical investigation to provide substantial evidence to support approval

FDA | Image credit: Postmodern Studio.jpeg
FDA Issues CRL for Vusolimogene Oderparepvec in Advanced Melanoma

July 22nd 2025

UV Safety Awareness Month | Image Credit: Nass Studio - stock.adobe.com
Sun Exposure Risks Brought to Light During UV Safety Awareness Month

July 1st 2025

Outside of patient diversity, the researchers call for variety in data types to strengthen AI models, with a compilation of patient records with genomic data and images. | Image credit: natali_mis - stock.adobe.com
Challenges and Opportunities for AI in Melanoma Detection

July 1st 2025

Whole-exome sequencing would help define mutations tied to micrometastasis and help further refine risk stratification. | Image credit: Seventyfour - stock.adobe.com
Mitotic Rate, Lymphovascular Invasion Among Risk Factors for Relapse in Melanoma

June 25th 2025

Dr. Jason Luke leads a panel discussing immunotherapy advances in Cutaneous and Basal Cell Carcinoma

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo